- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 213/71 - Sulfur atoms to which a second hetero atom is attached
Patent holdings for IPC class C07D 213/71
Total number of patents in this class: 413
10-year publication summary
|
29
|
42
|
30
|
34
|
32
|
26
|
15
|
29
|
17
|
8
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Sumitomo Chemical Company, Limited | 9043 |
19 |
| ImmunoGen, Inc. | 401 |
14 |
| Amgen Inc. | 4076 |
13 |
| Novartis AG | 10744 |
11 |
| Bristol-myers Squibb Company | 4880 |
9 |
| F. Hoffmann-La Roche AG | 7947 |
9 |
| Takeda Pharmaceutical Company Limited | 2708 |
9 |
| The Provost, Fellows, Foundation Scholars, and The Other Members of Board, of The College of The Holy and Undivided Trinity of Queen Elizabeth, Near Dublin | 165 |
7 |
| Ube Industries, Ltd. | 845 |
7 |
| The University of Queensland | 661 |
7 |
| Arcus Biosciences, Inc. | 139 |
6 |
| Inflazome Limited | 85 |
6 |
| Oxford Drug Design Limited | 9 |
6 |
| The Johns Hopkins University | 5675 |
5 |
| Cardioxyl Pharmaceuticals, Inc. | 49 |
5 |
| Sanofi | 4072 |
5 |
| BASF SE | 20940 |
4 |
| Syngenta Crop Protection AG | 6074 |
4 |
| Board of Regents, The University of Texas System | 5808 |
4 |
| Baylor College of Medicine | 950 |
4 |
| Other owners | 259 |